These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. To the editor: role of synalbumin insulin antagonist in the pathogenesis of diabetes mellitus. Vallance-Owen J; Bajaj JS Metabolism; 1971 May; 20(5):521-7. PubMed ID: 5580875 [No Abstract] [Full Text] [Related]
7. The Vallance-Owen ("synalbumin") insulin antagonist. Reproducibility and reliability of results in nondiabetic and diabetic humans. Sherman L Diabetes; 1966 Mar; 15(3):149-59. PubMed ID: 5909494 [No Abstract] [Full Text] [Related]
8. The inheritance of essential diabetes mellitus from studies of the synalbumin insulin antagonist. Vallance-Owen J Diabetologia; 1966 Dec; 2(4):248-52. PubMed ID: 6005204 [No Abstract] [Full Text] [Related]
9. Failure of synalbumin to exhibit insulin antagonism in vivo. Davidson MB; Goodner CJ Diabetes; 1967 Jun; 16(6):386-94. PubMed ID: 6025265 [No Abstract] [Full Text] [Related]
10. Antagonism between glucose and epinephrine regarding insulin secretion. A dose-response study in man. Cerasi E; Luft R; Efendić S Acta Med Scand; 1971 Nov; 190(5):411-7. PubMed ID: 4337656 [No Abstract] [Full Text] [Related]
11. Synalbumin insulin antagonism and protein synthesis. Bajaj JS; Bansal DD; Jindal HO Acta Diabetol Lat; 1974; 11(6):428-31. PubMed ID: 4478937 [No Abstract] [Full Text] [Related]
16. Diabetic neuropathy--clinical and electrophysiological study in synalbumin positive and synalbumin negative subjects. Chopra JS; Connon JJ; Banerji NK Diabetologia; 1969 Dec; 5(6):413-5. PubMed ID: 5372894 [No Abstract] [Full Text] [Related]
17. Effects of the synalbumin insulin antagonist in vivo; its examination with a new method. Kammerer L; Bretán M; Steingaszner O Diabetologia; 1970 Oct; 6(5):473-4. PubMed ID: 5474812 [No Abstract] [Full Text] [Related]